Results 191 to 200 of about 5,170,245 (289)

Efficacy and Safety of Laser-Based Therapies for Melasma: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Aljoaib NN, Baltoyour A, Al-Sharif M, Salem HE, Alsharif SM, Alzahrani SJ, Alotbi TH, Maghazel RH, Alqarni OS, Alsayed SA, Alkhalagi RF, Najmi EA, Altowerki BA, Alluhaibi ST, Alrehaili LA.   +14 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Landscape Characteristics and Distribution of Suitable Habitats for the Black-Tailed Godwit During the Non-Breeding Season: A Case Study of the Middle and Lower Yangtze River Region. [PDF]

Animals (Basel)
Jiang Z, Shao M.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

QSAR Models for Repeated Dose Toxicity in Rats Using the CORAL Software. [PDF]

Toxics
Toropova AP, Toropov AA, Iovine N, Selvestrel G, Roncaglioni A, Benfenati E.   +5 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Salvage of preputial flap necrosis in penile glans melanosis using Integra dermal regeneration template and split-thickness skin graft: A case report. [PDF]

Medicine (Baltimore)
Wang W, Lou YF, Yang LF, Zhou P.
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Applying machine learning to associate clinical factors with malnutrition risk in peritoneal dialysis patients: an internally validated interpretable model. [PDF]

Front Nutr
Cai J, Liu C, Zhang Y, Shi Y.
europepmc   +1 more source